<DOC>
	<DOCNO>NCT02163616</DOCNO>
	<brief_summary>This study seek ass whether population woman Latin America outside Quito , Ecuador increase risk develop elevate body temperature 40.0°C follow PPH treatment 800mcg sublingual misoprostol . The study carry hospital representative different region Latin America explore environmental genetic hypothesis relate occurrence misoprostol-induced fever . Postpartum blood loss , pulse blood pressure systematically measure woman enrol explore new clinical indicator identify woman require clinical intervention excessive bleeding . Blood sample collect among woman treat misoprostol investigate genetic factor responsible elevate body temperature induce misoprostol . The investigator hypothesize rate high fever ( ≥40.0°C ) follow misoprostol treatment ( 800mcg give sublingually ) variable across setting . The investigator expect side effect profile follow 800 mcg misoprostol give sublingually , particular rate shiver fever ≥38.0°C , comparable previous result use misoprostol PPH .</brief_summary>
	<brief_title>Treatment Postpartum Hemorrhage With Misoprostol : Fever Study</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<criteria>Able willing give inform consent Vaginal delivery Postpartum hemorrhage due suspect uterine atony Able willing give inform consent Known allergy misoprostol prostaglandins Underwent csection current delivery Unable provide inform consent due mental impairment , distress labor reason Unwilling and/or unable respond brief questionnaires blood drawn</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Primary postpartum hemorrhage</keyword>
	<keyword>PPH</keyword>
	<keyword>uterine atony</keyword>
	<keyword>high fever</keyword>
	<keyword>hyperpyrexia</keyword>
	<keyword>shock index</keyword>
</DOC>